Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
22.48
-0.78 (-3.35%)
At close: Apr 24, 2026, 4:00 PM EDT
22.47
-0.01 (-0.03%)
After-hours: Apr 24, 2026, 7:59 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$1,733,896
Market Cap
2.24B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Adaptive Biotechnologies | 624 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Day One Biopharmaceuticals | 178 |
DFTX News
- 3 days ago - Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day - Business Wire
- 3 days ago - Definium Therapeutics Transcript: Investor Day 2026 - Transcripts
- 5 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 5 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 5 days ago - Psychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug Research - Forbes
- 5 days ago - Psychedelic stocks rally with Trump's support - Market Watch
- 5 days ago - Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring. - Barrons
- 6 days ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters